BIO Releases New Study Showing Industry/University Partnerships Critical to U.S. Economy

A compilation of the survey results is available at http://bio.org/ip/techtransfer/PDF.TECH.TRANSFER.PRESENTATION.10.25.pdf and a detailed summary of the results is available at http://bio.org/ip/techtransfer/Tech.Transfer.Survey.Summary.Conclusions.doc.

Symposium Update: Presentations and Twitters

I’ll be posting the Symposium presentations on the website soon. 

In the meantime you can follow my session updates on twitter: www.twitter.com/margaritaatbio

Symposium News: BIO Publishes Study on Economic Impact of Bayh-Dole

BIO commissioned an analysis of the economic impact of Bayh-Dole, to be discussed by head researcher David Roessner of the Georgia Institute of Technology during the Technology Transfer Symposium. The study includes important findings on what technology transfer contributes to the U.S. economy.

William Young, Chairmen of BayBio Board of Directors, to Open Symposium

Today we are confirming that the Tech Transfer Symposium Mr. William D. Young, President & CEO, Monogram Biosciences and  Chairman, BayBio Board of Directors, will open the Symposium during its Welcome remarks alongside BIO’s Technology Transfer Committee chair W. Mark Crowell, Vice President of Business Development, Scripps Research Institute.

Mr. Young joined Monogram Biosciences (formerly ViroLogic) as Chairman of the Board and CEO in November 1999. From 1980 until joining Monogram, Bill was employed at Genentech, Inc., most recently as Chief Operating Officer. As COO, Bill was responsible for all of the company’s development (medical affairs, product development, pharmacological and process sciences, regulatory affairs), operations (manufacturing, quality, engineering), and commercial (marketing, sales, business development) functions.

Prior to joining Genentech, Bill worked at Eli Lilly and Company for 14 years and held various positions in production and process engineering, antibiotic process development, and production management. He received his bachelor’s degree in chemical engineering from Purdue University and his master’s of business administration from Indiana University. In 1993 he was elected to membership in the National Academy of Engineering division of the National Academy of Sciences for his contributions to the development of manufacturing technology for biotechnology-based drug products and in 2000 was awarded an Honorary Doctorate of Engineering by his alma mater, Purdue University. (BayBio)

BIO’s tech transfer community is proud to have Mr. Young join us at the Symposium, a first-of-its-kind public event organized by BIO to bring academia, researchers, policy makers, company, and venture capitalists together to discuss technology transfer policy trends.

BIO’s Technology Transfer Community Online

On behalf of the Biotechnology Industry Organization, welcome! We created this website to provide resources and connect the technology transfer community in the biotechnology industry.

The Technology Transfer Symposium on Wednesday, October 28, 2009 in San Francisco, CA is a first-of-its kind event where universities, companies, investors, and non-profit patient advocacy groups will consider today’s important innovation policy trends in the biotechnology industry.

This website contains policy, news, and conference information for attendees. For more information on the Symposium and to register, visit the Symposium page.

To learn more about technology transfer, visit the Policy and News pages.

Enjoy!